Home/Filings/4/0001104659-23-058582
4//SEC Filing

Manting Erik 4

Accession 0001104659-23-058582

CIK 0001829635other

Filed

May 9, 8:00 PM ET

Accepted

May 10, 6:13 PM ET

Size

5.5 KB

Accession

0001104659-23-058582

Insider Transaction Report

Form 4
Period: 2023-05-10
Manting Erik
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-05-10+9,5009,500 total
    Exercise: $0.30Exp: 2033-05-09Common Stock (9,500 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) May 10, 2024 and (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.

Issuer

Transcode Therapeutics, Inc.

CIK 0001829635

Entity typeother

Related Parties

1
  • filerCIK 0001856180

Filing Metadata

Form type
4
Filed
May 9, 8:00 PM ET
Accepted
May 10, 6:13 PM ET
Size
5.5 KB